- Title
- An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21 days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer
- Creators
- Peter G. Rose (Author)Bradley J. Monk (Author) - Creighton UniversityDiane Provencher (Author)Jean Hartney (Author)Philippe Legenne (Author)Stephen Lane (Author)
- Publication Details
- Gynecologic Oncology, Vol.120(1), pp.38-42
- Number of pages
- 38-42
- Identifiers
- 991005931413402656
- Academic Unit
- School of Medicine; Obstetrics & Gynecology
- Resource Type
- Journal article
Journal article
An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21 days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer
Gynecologic Oncology, Vol.120(1), pp.38-42
01/2011
PMID: 21055798
Metrics
3 Record Views